Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,169,439
-$2,243,452 QoQ
Shares Held
24,292
-29.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#1,466
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $52,280,324 across 9 Drug Manufacturers - General names. JNJ ranks #5 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
87,982 | $11,305,687 | |
| 2 | ABBV |
AbbVie Inc.
|
31,610 | $7,954,340 | |
| 3 | LLY |
ELI LILLY & Co
|
5,597 | $6,713,210 | |
| 4 | AZN |
Astrazeneca PLC
|
32,868 | $6,232,430 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
24,292 | $6,169,439 | |
| 6 | NVO |
Novo Nordisk A S
|
107,307 | $5,144,297 | |
| 7 | NVS |
Novartis AG
|
30,427 | $4,768,519 | |
| 8 | AMGN |
Amgen Inc
|
9,364 | $3,390,891 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,169,439 | 24,292 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $8,412,891 | 34,417 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $7,188,201 | 34,734 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $6,574,251 | 35,456 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $6,241,059 | 40,858 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $6,350,676 | 38,294 | Shares | Sole | 2025-04-16 | |
| 2024-09-30 | $6,030,738 | 37,213 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $6,943,184 | 47,504 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $7,251,429 | 45,840 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $7,069,757 | 45,105 | Shares | Sole | 2024-04-01 | |
| 2023-09-30 | $6,925,423 | 44,465 | Shares | Sole | 2024-04-01 | |
| 2023-06-30 | $7,878,089 | 47,596 | Shares | Sole | 2024-04-01 | |
| 2023-03-31 | $7,309,955 | 47,161 | Shares | Sole | 2024-04-01 | |
| 2022-12-31 | $8,217,581 | 46,519 | Shares | Sole | 2024-04-01 | |
| 2022-09-30 | $12,582,313 | 77,022 | Shares | Sole | 2024-04-01 | |
| 2022-06-30 | $13,479,399 | 75,936 | Shares | Sole | 2024-04-01 | |
| 2022-03-31 | $7,786,954 | 43,937 | Shares | Sole | 2024-04-01 | |
| 2021-12-31 | $6,647,951 | 38,861 | Shares | Sole | 2024-04-01 | |
| 2021-09-30 | $6,097,109 | 37,753 | Shares | Sole | 2024-04-01 | |
| 2021-06-30 | $6,066,550 | 36,825 | Shares | Sole | 2024-04-01 | |
| 2021-03-31 | $5,871,403 | 35,725 | Shares | Sole | 2024-04-01 | |
| 2020-12-31 | $5,512,706 | 35,028 | Shares | Sole | 2024-04-01 | |
| 2020-09-30 | $5,016,809 | 33,697 | Shares | Sole | 2024-04-01 | |
| 2020-06-30 | $4,383,718 | 31,172 | Shares | Sole | 2024-04-01 | |
| 2020-03-31 | $3,780,346 | 28,829 | Shares | Sole | 2024-04-01 | |
| No filing history on record for this holder in this stock. | ||||||